Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Participants with higher serum 25(OH)D levels were significantly less likely to report problems with mobility, usual activities, and depression and anxiety.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This is a cross-sectional study based on information gathered at baseline visits from volunteer participants before starting a wellness programme by the Pure North S’Energy Foundation (PN).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Vitamin D and health-related quality of life in a community sample of older Canadians

Cross-sectional study · Quality of Life Research · 2014

Original publication title

Vitamin D and health-related quality of life in a community sample of older Canadians

Y. S. Chao; J. P. Ekwaru; A. Ohinmaa; G. Griener; P. J. Veugelers

© The Author(s) 2014

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This is the first study to reveal the importance of vitamin D for the five dimensions of HRQOL in a community-based sample. The observed associations of vitamin D and HRQOL call for intervention studies to strengthen the evidence of the potential benefits of vitamin D supplementation for HRQOL among older adults.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To assess how vitamin D status is associated with health-related quality of life (HRQOL) among older residents of Canada.

Source: Purpose

Study methods

What methods does the paper describe?

This is a cross-sectional study based on information gathered at baseline visits from volunteer participants before starting a wellness programme by the Pure North S’Energy Foundation (PN). PN, a charitable, not-for-profit organization, provides a lifestyle counselling programme as described in more detail elsewhere [6, 17, 18]. As of August of 2012, PN started the recruitment of older residents of the city of Calgary, Alberta, Canada. PN advertised their programme for seniors through local newsletters and through the distribution of flyers in senior homes and community centres.

PN would organize weekly information meetings after which attendees could elect to sign up to enrol the programme. The present study pertains to baseline observations of older residents recruited between August 2012 and April 2013.

At their baseline visit, participants completed a survey had their body height and weight measured and their blood drawn for the assessment of serum 25-hydroxyvitamin D (25(OH)D). The survey included the five-level EQ-5D (EQ-5D-5L) to measure health-related quality of life (HRQOL) [19]. The EQ-5D consists of a five-dimensional descriptive system asking whether participants have (1) no problems; (2) slight problems; (3) moderate problems; (4) severe problems; or (5) extreme conditions or are unable to perform or extreme conditions are fully constrained or restricted, with each of the following: (1) mobility; (2) self-care; (3) usual activities; (4) pain or discomfort; and (5) anxiety or depression [19].

HRQOL scores are based on responses to each of the five dimensions and were derived from the USA value sets [20]. The EQ-5D is an established and validated instrument [19] with the major advantages of being short and easy to complete [21].

The survey further included questions on age, gender, and income. Individuals and couples with an annual income of <$25,000 and of <$41,000, respectively [22], were considered as low income. Body mass index (BMI) was calculated on the basis of the measured heights and weights (weights in kilograms divided by the square of height in metres). Individuals with a BMI of 25 or more are considered overweight, and those with a BMI of 30 or more are considered obese [23].

Serum 25(OH)D is the established proxy for vitamin D status. Some have suggested that individuals with serum 25(OH)D levels below 25 nmol/L should be considered vitamin D deficiency and those with serum 25(OH)D levels of 25 or more and <50 nmol/L be considered vitamin D insufficiency. As recent studies have suggested extra-skeletal benefits, such as reduction in colorectal cancer and cardiovascular disease risk, for individuals with serum levels of 75 nmol/L or more [1, 24, 25], and given the large number of observations with serum levels above 75 nmol/L, we further categorized serum levels into ≥75 and <100, ≥100 and <125, and ≥125 nmol/L.

As descriptive statistics, we included the prevalence of problems in the five HRQOL dimensions by vitamin D category and by age, gender, income, and bodyweight status. We tested for differences in the prevalence of HRQOL problems across vitamin D status categories by the use of univariate logistic regression. We applied univariate and multivariable logistic regression to quantify the association of vitamin D status with problems in each of the five HRQOL domains whereby we had dichotomized the latter into ‘having no problems’ (level 1) and ‘having problems’ (levels 2 to 5 combined).

As HRQOL scores were skewed to the left, with values ranging from 0.129 to 1.0, we log-transformed inverse of the HRQOL scores, i.e. log10(1.0001 − HRQOL). These ‘log of inverse HRQOL scores’ increase with poorer HRQOL and constitute the dependent variables in univariate and multivariable linear regression analyses to quantify the significance of vitamin D status for overall HRQOL. p values <0.05 were considered statistically significant.

PN anonymized their data prior to forwarding it to the University of Alberta for statistical analysis. The analysis was conducted using STATA version 12 (College Station, Texas). The Human Research Ethics Board of the University of Alberta approved the data access and analysis for this study.

Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods

Abstract: Design

We analysed baseline data of 1,493 Canadians aged 50 years and over in Alberta on HRQOL (EQ-5D-5L) and serum 25-hydroxyvitamin D (25(OH)D) as a measure of vitamin D status. We applied multivariable regression methods to examine the association between vitamin D status and each of the five dimensions and the summary index of the EQ-5D-5L.

Source: Design

Discussion

This is the first study to report on the associations of vitamin D with each of the five dimensions of quality of life. The study revealed significant associations of vitamin D with problems with mobility, usual activities, and depression and anxiety. It further revealed that an increase of 100 nmol/L of serum 25(OH)D is associated with an average increase of 29 % in HRQOL.

The average serum 25(OH)D level of participants was 92.44 nmol/L which is substantially higher than the average among Canadians aged 6 to 79 (67.7 nmol/L) and among Canadians 60 to 79 years of age (72.0 nmol/L) [5]. Self-selection of health aware individuals interested to participate in the wellness programme may have contributed to this. Health aware individuals may eat healthier and comply better with the existing vitamin D supplementation recommendations. This self-selection may particularly apply to individuals with pain and discomfort.

We observed that approximately 80 % of participants reported problems with pain and discomfort. This percentage seems higher than those of a population-based survey using EQ-5D-3L conducted in 2010 in the same province where 57 % of participants between the ages of 45 and 64 years and 66 % of participants 65 years of age and older reported problems with pain and discomfort [26]. Subjects experiencing pain and discomfort may be particularly motivated to participant in the programme.

Gender and age are established determinants of vitamin D status [6, 17] and of quality of life [20]. It is, therefore, essential to adjust for the confounding influence of gender and age as we did in this study. We observed that vitamin D was associated with three of the five EQ-5D dimensions: mobility, usual activities, and depression or anxiety. The absence of a statistical significant association with self-care may stem from the very low prevalence of reported problems with self-care in this population.

Bias by indication [27], whereby individuals with symptoms, pain, and illness are more likely to comply with recommendations, may have led to an underestimation of the strength of the association with each of the five dimensions. However, this may be particularly true for problems with ‘pain and discomfort’ and explain why no association for this dimension was observed.

Vitamin D has been shown to lead to better muscle strength [28], and, both in observational studies and clinical trials, vitamin D supplementation has been shown to benefit mobility and functional status in terms of prevention of falls [9] and improvement of physical function [29]. Consistent with our observations that individuals with a better vitamin D status reported less problems with mobility and usual activities, these findings [9, 29] seem to suggest less frailty among individuals with a good vitamin D status, though a recent meta-analysis reported that vitamin D supplementation among unselected community-dwelling individuals does not change risk for skeletal or non-skeletal outcomes by more than 15 % [30].

Vitamin D has also been shown to be associated with less depression [14] which seems consistent with our observation that higher vitamin D serum levels are associated with less problems with depression and anxiety. Though the associations with several outcomes are probable, more research is needed for more convincing evidence [31], which may particularly apply to mental health outcomes.

The Institute of Medicine recommendations are issued to the general public, but no earlier study had reported on the association between vitamin D and quality of life in a general population. Though we conducted this in a community sample, caution is warranted when it comes the generalizing our findings as this sample may be self-selected towards a health aware subpopulation with a relatively high prevalence of problems with pain and discomfort. Despite the large sample size, a second study limitation relates to the small number of participants that reported problems with self-care, which hampered some of the analyses.

Further, although we did adjust for the confounding effect of age, sex, income, and body weight status, we acknowledge that other factors may have confounded the observed association of 25(OH)D and HRQOL. Further, limitations relate to the cross-sectional design and the existence of reverse causation whereby, for example, individuals with limited mobility due to chronic diseases have less opportunity to get outdoors. A final limitation relates to the use of self-reported information that is prone to error, though the EQ-5D is an established and validated instrument [19] whereby the reporting error is expected to be limited given that it is short and easy to complete [21].

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Results

The mean serum 25(OH)D level among the 1,493 participants was 92.44 nmol/L and ranged from 12 to 319 nmol/L. Thirteen participants (0.9 %) had serum 25(OH)D levels of <25 nmol/L, and 116 (7.8 %) had 25(OH)D levels between 25 and 50 nmol/L (Table 1). Table 1 shows prevalence of problems by vitamin D status for each of the five EQ-5D dimensions and for any of these five problems. Though there are some slight fluctuations, the percentages of participants having problems in each of the five EQ-5D dimensions generally declined with higher categories of serum 25(OH) D.

Table 1 also shows associations between age, gender, income, and body weight and HRQOL. These associations are mostly substantial in magnitude and statistically significant.

Table 1

Prevalence of problems in the EQ-5D dimensions among 1,493 study participants

VariableNProblems with mobilityProblems with self-careProblems with usual activitiesProblems with pain and discomfortProblems with depression and anxietyAny problem
% p value% p value% p value% p value% p value% p value
25(OH)D level
<25 nmol/L1353.80.657.70.8438.51.0076.90.5861.50.6492.30.88
≥25, <50 nmol/L11647.40.9812.10.0351.7<.0180.20.4862.10.1891.40.89
≥50, <75 nmol/L38547.5ref.6.2ref.38.4ref.83.1ref.55.1ref.90.9ref.
≥75, <100 nmol/L46139.00.016.30.9738.40.9979.80.2354.40.8689.20.42
≥100, <125 nmol/L29035.2<.015.50.7133.80.2279.70.2653.40.6885.90.04
>125 nmol/L22834.2<.017.50.5635.10.4178.90.2149.10.1586.00.06
Gender
Female97140.80.786.70.8839.50.1082.9<.0159.5<.0190.6<.01
Male52240.0ref.6.9ref.35.2ref.76.1ref.44.4ref.85.1ref.
Age (years)
50 to 5935636.2<.015.9<.0140.40.0182.30.7065.7<.0191.90.38
60 to 6968738.9<.015.1<.0134.2<.0180.50.9953.90.1688.20.93
70 to 7936343.0<.018.0<.0138.8<.0178.80.7245.70.9786.50.60
80+8760.9ref.18.4ref.55.2ref.80.5ref.46.0ref.88.5ref.
Income
Other85333.5ref.4.1ref.30.4ref.77.7ref.51.2ref.86.3ref.
Low income64049.8<.0110.3<.0148.3<.0184.2<.0158.3<.0191.9<.01
Weight status
Underweight or normal weight47926.9ref.5.8ref.29.6ref.76.0ref.54.5ref.86.0ref.
Overweight59340.5<.015.20.6936.90.0180.80.0552.60.5489.40.08
Obesity42156.1<.0110.00.0149.2<.0185.3<.0156.30.5990.70.03

Ref.: reference category, 25(OH)D: serum 25-hydroxyvitamin D level, p value: Compared with the reference category

Table 2 shows the unadjusted and adjusted associations between 25(OH)D levels and having problems in each of the five EQ-5D dimensions. In the unadjusted analysis, each 100 nmol/L increase in 25(OH)D was significantly associated with a reduction in the odds of having problems with mobility (39 %), usual activities (30 %), pain and discomfort (26 %), and any problem (37 %). These associations remained statistically significant after adjusting for age and gender. Further, adjustment for income and body weight reduced the magnitude of the associations and only the association with anxiety or depression and any problem remained statistically significant.

Table 2

Changes in the odds of each EQ-5D dimension problems per 100 nmol increase in 25(OH)D/L among 1,493 study participants

ProblemUnadjustedAdjusted for age and genderAdjusted for age, gender, income, and weight status
Odds ratio95 % CI p valueOdds ratio95 % CI p valueOdds ratio95 % CI p value
Problems with mobility0.610.46 to 0.80<.010.580.44 to 0.78<.010.820.61 to 1.100.18
Problems with self-care0.890.52 to 1.530.680.880.51 to 1.520.651.110.65 to 1.910.70
Problems with usual activities0.700.53 to 0.920.010.670.50 to 0.89<.010.870.65 to 1.180.37
Problems with pain and discomfort0.850.61 to 1.170.320.790.57 to 1.100.160.950.67 to 1.340.77
Problems with depression and anxiety0.740.57 to 0.970.030.670.51 to 0.88<.010.710.53 to 0.940.02
Any problem0.630.43 to 0.910.020.580.39 to 0.84<.010.660.44 to 0.980.04

CI confidence interval, 25(OH)D serum 25-hydroxyvitamin D level

Figure 1 shows the mean values of HRQOL scores measured with EQ-5D-5L by vitamin D status. The mean HRQOL scores increased with increasing levels of vitamin D. Table 3 shows unadjusted and adjusted associations between the log of inverse HRQOL score and vitamin D levels, gender, age, weight status, and income. After adjusting for gender, age, weight status, and income, each 100 nmol/L increase in vitamin D level was associated with a 0.15 (95 % CI 0.01, 0.29) statistically significant reduction in the log of inverse HRQOL score, which corresponds to a statistically significant increase in HRQOL score.

A reduction in 0.15 in the log of inverse HRQOL score (1 − HRQOL) is equivalent to an increase in HRQOL score of about 291-HRQOL0HRQOL0% at any given initial HRQOL score HRQOL0. Therefore, at a HRQOL score of 0.5 a 100 nmol/L increase in 25(OH)D results in a 29 % increase in HRQOL score.

The percentage increase is higher than 29 % if the initial HRQOL score is below less 0.5 and <29 % if the initial HRQOL score is above 0.5.

Fig. 1

Mean HRQOL score by vitamin D category among 1,493 study participants. 25(OH)D serum 25-hydroxyvitamin D level, HRQOL health-related quality of life.

Figure image at the original source: open the original paper. This file is not included in this text import.

Table 3

Effect of serum 25(OH)D levels, gender, age, weight status, and income on the log-transformed inverse of health-related quality of life score (i.e. log10[1.0001 − HRQOL]) among 1,493 study participants

VariableUnadjustedAdjusted for age and genderAdjusted for age, gender, income, and weight status
β (95 % CI) p value β (95 %CI) p value β (95 % CI) p value
Serum 25(OH)D (100 nmol/L)−0.19 (−0.32,−0.05)0.009−0.22 (−0.36,−0.08)0.002−0.15 (−0.29,−0.01)0.042
Gender
Femaleref.ref.ref.
Male−0.20 (−0.31,−0.09)<.001−0.22 (−0.33,−0.10)<.001−0.22 (−0.33,−0.10)<.001
Age(years)
50 to 59ref.ref.ref.
60 to 69−0.14 (−0.27,0.00)0.050−0.11 (−0.25,0.02)0.095−0.15 (−0.28,−0.01)0.034
70 to 79−0.18 (−0.33,−0.02)0.025−0.16 (−0.32,−0.01)0.037−0.22 (−0.38,−0.07)0.005
80+−0.07 (−0.32,0.18)0.587−0.04 (−0.29,0.20)0.732−0.12 (−0.37,0.12)0.330
Weight status
Underweight or normal weightref.ref.
Overweight0.12 (−0.01,0.24)0.0730.16 (0.03,0.28)0.018
Obesity0.21 (0.07,0.35)0.0030.21 (0.06,0.35)0.005
Income
Low income0.24 (0.14,0.35)<.0010.23 (0.12,0.34)<.001
Otherref.ref.

In the above analyses, interaction terms of age and serum 25(OH)D were not associated with health-related quality of life in a statistical significantly manner

β coefficient, CI confidence interva, 25(OH)D serum 25-hydroxyvitamin D leve, Ref. reference category, HRQOL health-related quality of life

Source: Results Source: Results Source: Results

Abstract: Conclusions

This is the first study to reveal the importance of vitamin D for the five dimensions of HRQOL in a community-based sample. The observed associations of vitamin D and HRQOL call for intervention studies to strengthen the evidence of the potential benefits of vitamin D supplementation for HRQOL among older adults.

Source: Conclusions
Authors’ abstract

Purpose

To assess how vitamin D status is associated with health-related quality of life (HRQOL) among older residents of Canada.

Design

We analysed baseline data of 1,493 Canadians aged 50 years and over in Alberta on HRQOL (EQ-5D-5L) and serum 25-hydroxyvitamin D (25(OH)D) as a measure of vitamin D status. We applied multivariable regression methods to examine the association between vitamin D status and each of the five dimensions and the summary index of the EQ-5D-5L.

Results

Participants with higher serum 25(OH)D levels were significantly less likely to report problems with mobility, usual activities, and depression and anxiety. Specifically, age: and gender-adjusted odds ratios for reporting problems with mobility, usual activities, and depression and anxiety were 0.58 (95 % confidence interval 0.44 to 0.78), 0.67 (0.50 to 0.89), and 0.67 (0.51 to 0.88) per 100 nmol/L increase in 25(OH)D, respectively. No significant associations were observed for problems with self-care and with pain and discomfort. HRQOL scores combining the responses of each of the five dimensions increased significantly with increasing serum 25(OH)D levels.

Conclusions

This is the first study to reveal the importance of vitamin D for the five dimensions of HRQOL in a community-based sample. The observed associations of vitamin D and HRQOL call for intervention studies to strengthen the evidence of the potential benefits of vitamin D supplementation for HRQOL among older adults.

Read the full paper

Introduction

Vitamin D has been shown to affect bone health and various chronic diseases [1]. To mediate on the burden of some of these conditions, the Institute of Medicine and Health Canada recommend vitamin D supplementation of 600 IU per day for adults and 800 IU per day for those above the age of 70 years [2, 3]. Supplementation may be particularly important to residents of northern geographies, such as Canada, as subcutaneous creation of vitamin D by sun exposure is limited [4].

In Canada, vitamin D deficiency and insufficiency continue to be prevalent despite the recommendations for Vitamin D supplementation [5]. Specifically, the Canadian Health Measures Survey had shown that 4.1 and 10.6 % (95 % confidence interval 2.9 to 5.8 and 8.2 to 13.6 %, respectively) of Canadians aged 6 to 79 years had serum 25-hydroxyvitamin D <27.5 and 37.5 nmol/L, respectively [5]. We recently showed that the rates of deficiency and insufficiency were 3 and 8 %, respectively, in a sample of working age Canadians [6].

For older populations, several vitamin D supplementation studies have suggested, though not consistently, less functional limitation [7], prevention of falls [8Not reported10], reductions in fractures [11Not reported13], and mental health benefits [14, 15]. A meta-analysis by Bischoff-Ferrari et al. [9] concluded that in order to achieve a reduction in falls a supplementation dose of 700 to 1,000 IU per day is needed which is close to what is currently recommended by the Institute of Medicine.

The above studies suggest a relationship of vitamin D and objectively measured health conditions. Health-related quality of life (HRQOL) aims to quantify the subjective experiences of the consequences of these health conditions. The importance of vitamin D for HRQOL has been less studied. Huang et al. [16] attributed improvements in quality of life along with improvements in pain and sleep to vitamin D supplementation in a case series of individuals with chronic pain. However, to the best of our knowledge, no earlier studies have examined the association of vitamin D with the full spectrum of HRQOL in healthy populations.

We believe that this is particularly important as the Institute of Medicine recommendations are issued to the general public. We also believe these are particular important to Canadians given the relatively high latitude and consequent reliance on vitamin D from diet and supplements. In the present study, we assess the association of vitamin D status and HRQOL among older residents of Canada.

Methods

This is a cross-sectional study based on information gathered at baseline visits from volunteer participants before starting a wellness programme by the Pure North S’Energy Foundation (PN). PN, a charitable, not-for-profit organization, provides a lifestyle counselling programme as described in more detail elsewhere [6, 17, 18]. As of August of 2012, PN started the recruitment of older residents of the city of Calgary, Alberta, Canada. PN advertised their programme for seniors through local newsletters and through the distribution of flyers in senior homes and community centres.

PN would organize weekly information meetings after which attendees could elect to sign up to enrol the programme. The present study pertains to baseline observations of older residents recruited between August 2012 and April 2013.

At their baseline visit, participants completed a survey had their body height and weight measured and their blood drawn for the assessment of serum 25-hydroxyvitamin D (25(OH)D). The survey included the five-level EQ-5D (EQ-5D-5L) to measure health-related quality of life (HRQOL) [19]. The EQ-5D consists of a five-dimensional descriptive system asking whether participants have (1) no problems; (2) slight problems; (3) moderate problems; (4) severe problems; or (5) extreme conditions or are unable to perform or extreme conditions are fully constrained or restricted, with each of the following: (1) mobility; (2) self-care; (3) usual activities; (4) pain or discomfort; and (5) anxiety or depression [19].

HRQOL scores are based on responses to each of the five dimensions and were derived from the USA value sets [20]. The EQ-5D is an established and validated instrument [19] with the major advantages of being short and easy to complete [21].

The survey further included questions on age, gender, and income. Individuals and couples with an annual income of <$25,000 and of <$41,000, respectively [22], were considered as low income. Body mass index (BMI) was calculated on the basis of the measured heights and weights (weights in kilograms divided by the square of height in metres). Individuals with a BMI of 25 or more are considered overweight, and those with a BMI of 30 or more are considered obese [23].

Serum 25(OH)D is the established proxy for vitamin D status. Some have suggested that individuals with serum 25(OH)D levels below 25 nmol/L should be considered vitamin D deficiency and those with serum 25(OH)D levels of 25 or more and <50 nmol/L be considered vitamin D insufficiency. As recent studies have suggested extra-skeletal benefits, such as reduction in colorectal cancer and cardiovascular disease risk, for individuals with serum levels of 75 nmol/L or more [1, 24, 25], and given the large number of observations with serum levels above 75 nmol/L, we further categorized serum levels into ≥75 and <100, ≥100 and <125, and ≥125 nmol/L.

As descriptive statistics, we included the prevalence of problems in the five HRQOL dimensions by vitamin D category and by age, gender, income, and bodyweight status. We tested for differences in the prevalence of HRQOL problems across vitamin D status categories by the use of univariate logistic regression. We applied univariate and multivariable logistic regression to quantify the association of vitamin D status with problems in each of the five HRQOL domains whereby we had dichotomized the latter into ‘having no problems’ (level 1) and ‘having problems’ (levels 2 to 5 combined).

As HRQOL scores were skewed to the left, with values ranging from 0.129 to 1.0, we log-transformed inverse of the HRQOL scores, i.e. log10(1.0001 − HRQOL). These ‘log of inverse HRQOL scores’ increase with poorer HRQOL and constitute the dependent variables in univariate and multivariable linear regression analyses to quantify the significance of vitamin D status for overall HRQOL. p values <0.05 were considered statistically significant.

PN anonymized their data prior to forwarding it to the University of Alberta for statistical analysis. The analysis was conducted using STATA version 12 (College Station, Texas). The Human Research Ethics Board of the University of Alberta approved the data access and analysis for this study.

Results

The mean serum 25(OH)D level among the 1,493 participants was 92.44 nmol/L and ranged from 12 to 319 nmol/L. Thirteen participants (0.9 %) had serum 25(OH)D levels of <25 nmol/L, and 116 (7.8 %) had 25(OH)D levels between 25 and 50 nmol/L (Table 1). Table 1 shows prevalence of problems by vitamin D status for each of the five EQ-5D dimensions and for any of these five problems. Though there are some slight fluctuations, the percentages of participants having problems in each of the five EQ-5D dimensions generally declined with higher categories of serum 25(OH) D.

Table 1 also shows associations between age, gender, income, and body weight and HRQOL. These associations are mostly substantial in magnitude and statistically significant.

Table 1

Prevalence of problems in the EQ-5D dimensions among 1,493 study participants

VariableNProblems with mobilityProblems with self-careProblems with usual activitiesProblems with pain and discomfortProblems with depression and anxietyAny problem
% p value% p value% p value% p value% p value% p value
25(OH)D level
<25 nmol/L1353.80.657.70.8438.51.0076.90.5861.50.6492.30.88
≥25, <50 nmol/L11647.40.9812.10.0351.7<.0180.20.4862.10.1891.40.89
≥50, <75 nmol/L38547.5ref.6.2ref.38.4ref.83.1ref.55.1ref.90.9ref.
≥75, <100 nmol/L46139.00.016.30.9738.40.9979.80.2354.40.8689.20.42
≥100, <125 nmol/L29035.2<.015.50.7133.80.2279.70.2653.40.6885.90.04
>125 nmol/L22834.2<.017.50.5635.10.4178.90.2149.10.1586.00.06
Gender
Female97140.80.786.70.8839.50.1082.9<.0159.5<.0190.6<.01
Male52240.0ref.6.9ref.35.2ref.76.1ref.44.4ref.85.1ref.
Age (years)
50 to 5935636.2<.015.9<.0140.40.0182.30.7065.7<.0191.90.38
60 to 6968738.9<.015.1<.0134.2<.0180.50.9953.90.1688.20.93
70 to 7936343.0<.018.0<.0138.8<.0178.80.7245.70.9786.50.60
80+8760.9ref.18.4ref.55.2ref.80.5ref.46.0ref.88.5ref.
Income
Other85333.5ref.4.1ref.30.4ref.77.7ref.51.2ref.86.3ref.
Low income64049.8<.0110.3<.0148.3<.0184.2<.0158.3<.0191.9<.01
Weight status
Underweight or normal weight47926.9ref.5.8ref.29.6ref.76.0ref.54.5ref.86.0ref.
Overweight59340.5<.015.20.6936.90.0180.80.0552.60.5489.40.08
Obesity42156.1<.0110.00.0149.2<.0185.3<.0156.30.5990.70.03

Ref.: reference category, 25(OH)D: serum 25-hydroxyvitamin D level, p value: Compared with the reference category

Table 2 shows the unadjusted and adjusted associations between 25(OH)D levels and having problems in each of the five EQ-5D dimensions. In the unadjusted analysis, each 100 nmol/L increase in 25(OH)D was significantly associated with a reduction in the odds of having problems with mobility (39 %), usual activities (30 %), pain and discomfort (26 %), and any problem (37 %). These associations remained statistically significant after adjusting for age and gender. Further, adjustment for income and body weight reduced the magnitude of the associations and only the association with anxiety or depression and any problem remained statistically significant.

Table 2

Changes in the odds of each EQ-5D dimension problems per 100 nmol increase in 25(OH)D/L among 1,493 study participants

ProblemUnadjustedAdjusted for age and genderAdjusted for age, gender, income, and weight status
Odds ratio95 % CI p valueOdds ratio95 % CI p valueOdds ratio95 % CI p value
Problems with mobility0.610.46 to 0.80<.010.580.44 to 0.78<.010.820.61 to 1.100.18
Problems with self-care0.890.52 to 1.530.680.880.51 to 1.520.651.110.65 to 1.910.70
Problems with usual activities0.700.53 to 0.920.010.670.50 to 0.89<.010.870.65 to 1.180.37
Problems with pain and discomfort0.850.61 to 1.170.320.790.57 to 1.100.160.950.67 to 1.340.77
Problems with depression and anxiety0.740.57 to 0.970.030.670.51 to 0.88<.010.710.53 to 0.940.02
Any problem0.630.43 to 0.910.020.580.39 to 0.84<.010.660.44 to 0.980.04

CI confidence interval, 25(OH)D serum 25-hydroxyvitamin D level

Figure 1 shows the mean values of HRQOL scores measured with EQ-5D-5L by vitamin D status. The mean HRQOL scores increased with increasing levels of vitamin D. Table 3 shows unadjusted and adjusted associations between the log of inverse HRQOL score and vitamin D levels, gender, age, weight status, and income. After adjusting for gender, age, weight status, and income, each 100 nmol/L increase in vitamin D level was associated with a 0.15 (95 % CI 0.01, 0.29) statistically significant reduction in the log of inverse HRQOL score, which corresponds to a statistically significant increase in HRQOL score.

A reduction in 0.15 in the log of inverse HRQOL score (1 − HRQOL) is equivalent to an increase in HRQOL score of about 291-HRQOL0HRQOL0% at any given initial HRQOL score HRQOL0. Therefore, at a HRQOL score of 0.5 a 100 nmol/L increase in 25(OH)D results in a 29 % increase in HRQOL score.

The percentage increase is higher than 29 % if the initial HRQOL score is below less 0.5 and <29 % if the initial HRQOL score is above 0.5.

Fig. 1

Mean HRQOL score by vitamin D category among 1,493 study participants. 25(OH)D serum 25-hydroxyvitamin D level, HRQOL health-related quality of life.

Figure image at the original source: open the original paper. This file is not included in this text import.

Table 3

Effect of serum 25(OH)D levels, gender, age, weight status, and income on the log-transformed inverse of health-related quality of life score (i.e. log10[1.0001 − HRQOL]) among 1,493 study participants

VariableUnadjustedAdjusted for age and genderAdjusted for age, gender, income, and weight status
β (95 % CI) p value β (95 %CI) p value β (95 % CI) p value
Serum 25(OH)D (100 nmol/L)−0.19 (−0.32,−0.05)0.009−0.22 (−0.36,−0.08)0.002−0.15 (−0.29,−0.01)0.042
Gender
Femaleref.ref.ref.
Male−0.20 (−0.31,−0.09)<.001−0.22 (−0.33,−0.10)<.001−0.22 (−0.33,−0.10)<.001
Age(years)
50 to 59ref.ref.ref.
60 to 69−0.14 (−0.27,0.00)0.050−0.11 (−0.25,0.02)0.095−0.15 (−0.28,−0.01)0.034
70 to 79−0.18 (−0.33,−0.02)0.025−0.16 (−0.32,−0.01)0.037−0.22 (−0.38,−0.07)0.005
80+−0.07 (−0.32,0.18)0.587−0.04 (−0.29,0.20)0.732−0.12 (−0.37,0.12)0.330
Weight status
Underweight or normal weightref.ref.
Overweight0.12 (−0.01,0.24)0.0730.16 (0.03,0.28)0.018
Obesity0.21 (0.07,0.35)0.0030.21 (0.06,0.35)0.005
Income
Low income0.24 (0.14,0.35)<.0010.23 (0.12,0.34)<.001
Otherref.ref.

In the above analyses, interaction terms of age and serum 25(OH)D were not associated with health-related quality of life in a statistical significantly manner

β coefficient, CI confidence interva, 25(OH)D serum 25-hydroxyvitamin D leve, Ref. reference category, HRQOL health-related quality of life

Discussion

This is the first study to report on the associations of vitamin D with each of the five dimensions of quality of life. The study revealed significant associations of vitamin D with problems with mobility, usual activities, and depression and anxiety. It further revealed that an increase of 100 nmol/L of serum 25(OH)D is associated with an average increase of 29 % in HRQOL.

The average serum 25(OH)D level of participants was 92.44 nmol/L which is substantially higher than the average among Canadians aged 6 to 79 (67.7 nmol/L) and among Canadians 60 to 79 years of age (72.0 nmol/L) [5]. Self-selection of health aware individuals interested to participate in the wellness programme may have contributed to this. Health aware individuals may eat healthier and comply better with the existing vitamin D supplementation recommendations. This self-selection may particularly apply to individuals with pain and discomfort.

We observed that approximately 80 % of participants reported problems with pain and discomfort. This percentage seems higher than those of a population-based survey using EQ-5D-3L conducted in 2010 in the same province where 57 % of participants between the ages of 45 and 64 years and 66 % of participants 65 years of age and older reported problems with pain and discomfort [26]. Subjects experiencing pain and discomfort may be particularly motivated to participant in the programme.

Gender and age are established determinants of vitamin D status [6, 17] and of quality of life [20]. It is, therefore, essential to adjust for the confounding influence of gender and age as we did in this study. We observed that vitamin D was associated with three of the five EQ-5D dimensions: mobility, usual activities, and depression or anxiety. The absence of a statistical significant association with self-care may stem from the very low prevalence of reported problems with self-care in this population.

Bias by indication [27], whereby individuals with symptoms, pain, and illness are more likely to comply with recommendations, may have led to an underestimation of the strength of the association with each of the five dimensions. However, this may be particularly true for problems with ‘pain and discomfort’ and explain why no association for this dimension was observed.

Vitamin D has been shown to lead to better muscle strength [28], and, both in observational studies and clinical trials, vitamin D supplementation has been shown to benefit mobility and functional status in terms of prevention of falls [9] and improvement of physical function [29]. Consistent with our observations that individuals with a better vitamin D status reported less problems with mobility and usual activities, these findings [9, 29] seem to suggest less frailty among individuals with a good vitamin D status, though a recent meta-analysis reported that vitamin D supplementation among unselected community-dwelling individuals does not change risk for skeletal or non-skeletal outcomes by more than 15 % [30].

Vitamin D has also been shown to be associated with less depression [14] which seems consistent with our observation that higher vitamin D serum levels are associated with less problems with depression and anxiety. Though the associations with several outcomes are probable, more research is needed for more convincing evidence [31], which may particularly apply to mental health outcomes.

The Institute of Medicine recommendations are issued to the general public, but no earlier study had reported on the association between vitamin D and quality of life in a general population. Though we conducted this in a community sample, caution is warranted when it comes the generalizing our findings as this sample may be self-selected towards a health aware subpopulation with a relatively high prevalence of problems with pain and discomfort. Despite the large sample size, a second study limitation relates to the small number of participants that reported problems with self-care, which hampered some of the analyses.

Further, although we did adjust for the confounding effect of age, sex, income, and body weight status, we acknowledge that other factors may have confounded the observed association of 25(OH)D and HRQOL. Further, limitations relate to the cross-sectional design and the existence of reverse causation whereby, for example, individuals with limited mobility due to chronic diseases have less opportunity to get outdoors. A final limitation relates to the use of self-reported information that is prone to error, though the EQ-5D is an established and validated instrument [19] whereby the reporting error is expected to be limited given that it is short and easy to complete [21].

The authors wish to thank the Pure North S’Energy Foundation for allowing their data to be analysed for the purpose of this article. They specifically wish to thank the Peter Tran and Ken Fyle for management and validation of the Foundation’s data. PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta.

The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S’Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions.

Conflict of interest

None.

References

1. Holick MF Vitamin D deficiency The New England Journal of Medicine 2007 357 3 266 281 10.1056/NEJMra070553 17634462
2. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Institute of Medicine, Dietary reference intakes for calcium and vitamin D 2011 Washington, D.C.The National Academies Press
3. Health Canada (2012) Vitamin D and calcium: Updated dietary reference intakes. Health Canada. http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php. Accessed October 20, 2013.
4. Prentice A Vitamin D deficiency: A global perspective Nutrition Reviews 2008 66 10 Suppl 2 S153 S164 10.1111/j.1753-4887.2008.00100.x 18844843
5. Langlois K Greene-Finestone L Little J Hidiroglou N Whiting S Vitamin D status of Canadians as measured in the 2007 to 2009 Canadian Health Measures Survey Health Report 2010 21 1 47 55 20426226
6. Chao YS Brunel L Faris P Veugelers PJ Vitamin D status of Canadians employed in northern latitudes Occupational Medicine (Oxford, England) 2013 63 7 485 493 10.1093/occmed/kqt106 24027218
7. Sohl E van Schoor NM de Jongh RT Visser M Deeg DJ Lips P Vitamin D status is associated with functional limitations and functional decline in older individuals The Journal of Clinical Endocrinology and Metabolism 2013 98 9 E1483 E1490 10.1210/jc.2013-1698 23864700
8. Murad MH Elamin KB Abu Elnour NO Elamin MB Alkatib AA Fatourechi MM Almandoz JP Mullan RJ Lane MA Liu H Erwin PJ Hensrud DD Montori VM Clinical review: The effect of vitamin D on falls: A systematic review and meta-analysis The Journal of Clinical Endocrinology and Metabolism 2011 96 10 2997 3006 10.1210/jc.2011-1193 21795448
9. Bischoff-Ferrari HA Dawson-Hughes B Staehelin HB Orav JE Stuck AE Theiler R Wong JB Egli A Kiel DP Henschkowski J Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials BMJ 2009 339 b3692 10.1136/bmj.b3692 19797342 PMC2755728
10. Janssen HC Samson MM Verhaar HJ Vitamin D deficiency, muscle function, and falls in elderly people The American Journal of Clinical Nutrition 2002 75 4 611 615 11916748 10.1093/ajcn/75.4.611
11. Bischoff-Ferrari HA Willett WC Orav EJ Lips P Meunier PJ Lyons RA Flicker L Wark J Jackson RD Cauley JA Meyer HE Pfeifer M Sanders KM Stähelin HB Theiler R Dawson-Hughes B A Pooled analysis of vitamin D dose requirements for fracture prevention New England Journal of Medicine 2012 367 1 40 49 10.1056/NEJMoa1109617 22762317
12. Sahota O Reducing the risk of fractures with calcium and vitamin D BMJ 2010 340 b5492 10.1136/bmj.b5492 20068259
13. Lips P Wiersinga A van Ginkel FC Jongen MJ Netelenbos JC Hackeng WH Delmas PD van der Vijgh WJ The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects The Journal of Clinical Endocrinology and Metabolism 1988 67 4 644 650 10.1210/jcem-67-4-644 3417845
14. Anglin RE Samaan Z Walter SD McDonald SD Vitamin D deficiency and depression in adults: systematic review and meta-analysis The British journal of psychiatry. 2013 202 100 107 10.1192/bjp.bp.111.106666 23377209
15. Ju SY Lee YJ Jeong SN Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis The Journal of Nutrition, Health & Aging 2013 17 5 447 455 10.1007/s12603-012-0418-0 PMC12878238 23636546
16. Huang W Shah S Long Q Crankshaw AK Tangpricha V Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation The Clinical Journal of Pain 2013 29 4 341 347 10.1097/AJP.0b013e318255655d 22699141
17. Chao YS Brunel L Faris P Veugelers PJ The importance of dose, frequency and duration of vitamin d supplementation for plasma 25-hydroxyvitamin d Nutrients 2013 5 10 4067 4078 10.3390/nu5104067 24152747 PMC3820059
18. Heaney RP French CB Nguyen S Ferreira M Baggerly LL Brunel L Veugelers P A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum Advance Nutrition 2013 4 3 303 310 10.3945/an.113.003731 PMC3650499 23674796
19. Oemar M, Janssen B (2013) EQ-5D-5L User guide basic information on how to use the EQ-5D-5L instrument. http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L_v2.0_October_2013.pdf [link unavailable]. Accessed March 15, 2014.
20. Herdman M Gudex C Lloyd A Janssen M Kind P Parkin D Bonsel G Badia X Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Quality of Life Research 2011 20 10 1727 1736 10.1007/s11136-011-9903-x 21479777 PMC3220807
21. Tidermark J Zethraeus N Svensson O Törnkvist H Ponzer S Femoral neck fractures in the elderly: Functional outcome and quality of life according to EuroQol Quality of Life Research 2002 11 5 473 481 10.1023/A:1015632114068 12113394
22. Harris M (2013) Digital divide persists in Canada, both in access and Internet fluency. Financial Post, March 21, 2013, p Tech Desk.
23. World Health Organization (2013) Obesity and overweight. World Health Organization. http://www.who.int/mediacentre/factsheets/fs311/en/index.html [link unavailable]. Accessed October 1, 2013.
24. Vieth R Bischoff-Ferrari H Boucher BJ Dawson-Hughes B Garland CF Heaney RP Holick MF Hollis BW Lamberg-Allardt C McGrath JJ Norman AW Scragg R Whiting SJ Willett WC Zittermann A The urgent need to recommend an intake of vitamin D that is effective The American Journal of Clinical Nutrition 2007 85 3 649 650 17344484 10.1093/ajcn/85.3.649
25. Health Quality Council of Alberta (2013). Alberta Provincial Norms for EQ-5D-3L. http://www.hqca.ca/assets/files/Alberta%20Provincial%20Norms%20for%20EQ-5D%203L(1).pdf [link unavailable]. Accessed March 15, 2014.
26. Bischoff-Ferrari HA Giovannucci E Willett WC Dietrich T Dawson-Hughes B Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes The American Journal of Clinical Nutrition 2006 84 1 18 28 16825677 10.1093/ajcn/84.1.18
27. Signorello LB McLaughlin JK Lipworth L Friis S Sorensen HT Blot WJ Confounding by indication in epidemiologic studies of commonly used analgesics American Journal of Therapeutics 2002 9 3 199 205 10.1097/00045391-200205000-00005 11941379
28. Ceglia L Feldman D Pike JW Adams JS Simpson RU (2011) Vitamin D and skeletal muscle function Vitamin D 2011 Amsterdam, The NetherlandsElsevier Science
29. Bunout D Barrera G Leiva L Gattas V de la Maza MP Avendano M Hirsch S Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects Experimental Gerontology 2006 41 8 746 752 10.1016/j.exger.2006.05.001 16797903
30. Bolland MJ Grey A Gamble GD Reid IR The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis The lancet Diabetes & Endocrinology 2014 2 4 307 320 10.1016/S2213-8587(13)70212-2 24703049
31. Theodoratou E Tzoulaki I Zgaga L Ioannidis JPA Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials BMJ 2014 348 g2035 10.1136/bmj.g2035 24690624 PMC3972415
Publication and source details

Original title: Vitamin D and health-related quality of life in a community sample of older Canadians

Y. S. Chao; J. P. Ekwaru; A. Ohinmaa; G. Griener; P. J. Veugelers

Quality of Life Research · 2014

© The Author(s) 2014https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:48:32.289182+00:00

DOI: 10.1007/s11136-014-0696-6 · PMC4186994